GILEAD SCIENCES, INC. ($GILD)
Filing Information
| Accession Number | 0001310204-26-000010 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 12, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
61,555
Total Value
$467,518.32
P&L
+inf% (+$4,923,094.80)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Mar 10, 2026 | Exercise/Conversion | 6,469 | โ | โ | 185,338 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 10, 2026 | Tax Withholding | 3,147 | $148.56 | $467,518.32 | 182,191 | Direct | โ | View Details | |
Chief Financial Officer | Restricted Stock Unit | Derivative | Mar 10, 2026 | Exercise/Conversion | 6,469 | โ | โ | 21,057 | Direct | โ | View Details | |
Chief Financial Officer | Restricted Stock Unit | Derivative | Mar 10, 2026 | Grant/Award | 9,590 | โ | โ | 30,647 | Direct | โ | View Details | |
Chief Financial Officer | Non-qualified Stock Option (Right to Buy) | Derivative | Mar 10, 2026 | Grant/Award | 35,880 | $0.00 | $0.00 | 35,880 | Direct | โ | View Details |